Chances are you will never see or hear about either disease in your lifetime. As I said in a previous post both conditions occur most commonly on board exams and in textbooks. If they can't fully enroll a 3 month acne trial how they gonna get 5 subjects with either disease- Long on Hype- will be short on delivery on this one as well but that's..JUST OPINION
Congrats on seeing xoma correctly. If xoma plans on developing xmet, etc with the newest funding, how does that get them past 'well into 2014' that they already have targeted for the money running out as far as the POC's and eyeguard trials. I forsee more funding shortages.
Do orphan drugs qualify for BLA priority application (avg 6 month approval)or would they still be considered standard application (average 1.5 years to approval)?
maybe you should look at sweets-syndrome. it is an address that has a commercial ending. probably some of those ladies would disagree with your numbers.